Wellpharma Launches Healthcare Investment Fund in Abu Dhabi

Wellpharma Holding, a company set up recently by Abu Dhabi Investment House, or ADIH, has launched a healthcare fund to raise finance to invest in a pharmaceutical plant to be established in the emmirate.

The new facility will specialise in the manufacturing of high-quality intravenous solutions for medical treatments.

The launch of Wellpharma Medical Solutions Fund is in line with Abu Dhabi Investment House’s strategy to diversify its investment products to venture into new sectors such as food security, energy and clean energy and healthcare.

The Ministry of Health and Health Authority in Abu Dhabi, or HAAD, have already agreed in principle to allow setting up of an intravenous solutions project in the emirate, a spokesperson of 
ADIH said.

Land for the project is being allocated as well as an industrial partner to help in building and operating the facility has also been identified.

“The Wellpharma Medical Solutions project will be the first among many in ADIH’s ‘Wellpharma’ product range. Other initiatives will include medical office buildings and other innovative medical products,” the investment house said.

The opportunity was identified after a thorough due diligence and realisation of current market situation where huge scope exists for such economic projects.

“The fund will take into consideration local and regional gaps in supply and demand of Intravenous Solutions to ensure the best returns,” he said.

Increasing gap between supply and demand as well as the implementation of mandatory health insurance within the GCC region will expand the healthcare sector by eight per cent annually in the next five years, the ADIH said.

Share/Save